Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase)

Masahiro Otomo, Kiyofumi Takahashi, Hiroshi Miyoshi, Kenichi Osada, Hideki Nakashima, Noboru Yamaguchi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Neuronal dynamin I plays a critical role in the recycling of synaptic vesicles, and thus in nervous system function. We expressed and purified dynamin I to explore potentially clinically useful endocytosis inhibitors and to examine the mechanism of their action. We estimated the IC50 of nineteen psychotropic drugs for dynamin I. The IC50 values of two selective serotonin reuptake inhibitors (sertraline and fluvoxamine) were 7.3±1.0 and 14.7±1.6 μM, respectively. Kinetic analyses revealed that fluvoxamine is a noncompetitive inhibitor of dynamin I guanosine triphosphatase (GTPase) with respect to guanosine 5′-triphosphate (GTP) and a competitive inhibitor with respect to L-phosphatidylserine (PS). Fluvoxamine may compete with PS for binding to the pleckstrin homology domain of dynamin I. On the other hand, sertraline was a mixed type inhibitor with respect to both GTP and PS. Our results indicate that sertraline and fluvoxamine may regulate the transportation of neurotransmitters by modulating synaptic vesicle endocytosis via the inhibition of dynamin I GTPase.

Original languageEnglish
Pages (from-to)1489-1495
Number of pages7
JournalBiological and Pharmaceutical Bulletin
Volume31
Issue number8
DOIs
Publication statusPublished - 2008 Aug
Externally publishedYes

Fingerprint

Dynamin I
Guanosine
Serotonin Uptake Inhibitors
Fluvoxamine
Sertraline
Phosphatidylserines
Synaptic Vesicles
Endocytosis
Guanosine Triphosphate
Inhibitory Concentration 50
Psychotropic Drugs
Nervous System
Neurotransmitter Agents

Keywords

  • Dynamin
  • Endocytosis
  • Guanosine triphosphatase
  • Inhibitor
  • Selective serotonin reuptake inhibitor

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase). / Otomo, Masahiro; Takahashi, Kiyofumi; Miyoshi, Hiroshi; Osada, Kenichi; Nakashima, Hideki; Yamaguchi, Noboru.

In: Biological and Pharmaceutical Bulletin, Vol. 31, No. 8, 08.2008, p. 1489-1495.

Research output: Contribution to journalArticle

Otomo, Masahiro ; Takahashi, Kiyofumi ; Miyoshi, Hiroshi ; Osada, Kenichi ; Nakashima, Hideki ; Yamaguchi, Noboru. / Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase). In: Biological and Pharmaceutical Bulletin. 2008 ; Vol. 31, No. 8. pp. 1489-1495.
@article{faa6a05ebd9a448f83cf312c7812cb35,
title = "Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase)",
abstract = "Neuronal dynamin I plays a critical role in the recycling of synaptic vesicles, and thus in nervous system function. We expressed and purified dynamin I to explore potentially clinically useful endocytosis inhibitors and to examine the mechanism of their action. We estimated the IC50 of nineteen psychotropic drugs for dynamin I. The IC50 values of two selective serotonin reuptake inhibitors (sertraline and fluvoxamine) were 7.3±1.0 and 14.7±1.6 μM, respectively. Kinetic analyses revealed that fluvoxamine is a noncompetitive inhibitor of dynamin I guanosine triphosphatase (GTPase) with respect to guanosine 5′-triphosphate (GTP) and a competitive inhibitor with respect to L-phosphatidylserine (PS). Fluvoxamine may compete with PS for binding to the pleckstrin homology domain of dynamin I. On the other hand, sertraline was a mixed type inhibitor with respect to both GTP and PS. Our results indicate that sertraline and fluvoxamine may regulate the transportation of neurotransmitters by modulating synaptic vesicle endocytosis via the inhibition of dynamin I GTPase.",
keywords = "Dynamin, Endocytosis, Guanosine triphosphatase, Inhibitor, Selective serotonin reuptake inhibitor",
author = "Masahiro Otomo and Kiyofumi Takahashi and Hiroshi Miyoshi and Kenichi Osada and Hideki Nakashima and Noboru Yamaguchi",
year = "2008",
month = "8",
doi = "10.1248/bpb.31.1489",
language = "English",
volume = "31",
pages = "1489--1495",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "8",

}

TY - JOUR

T1 - Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase)

AU - Otomo, Masahiro

AU - Takahashi, Kiyofumi

AU - Miyoshi, Hiroshi

AU - Osada, Kenichi

AU - Nakashima, Hideki

AU - Yamaguchi, Noboru

PY - 2008/8

Y1 - 2008/8

N2 - Neuronal dynamin I plays a critical role in the recycling of synaptic vesicles, and thus in nervous system function. We expressed and purified dynamin I to explore potentially clinically useful endocytosis inhibitors and to examine the mechanism of their action. We estimated the IC50 of nineteen psychotropic drugs for dynamin I. The IC50 values of two selective serotonin reuptake inhibitors (sertraline and fluvoxamine) were 7.3±1.0 and 14.7±1.6 μM, respectively. Kinetic analyses revealed that fluvoxamine is a noncompetitive inhibitor of dynamin I guanosine triphosphatase (GTPase) with respect to guanosine 5′-triphosphate (GTP) and a competitive inhibitor with respect to L-phosphatidylserine (PS). Fluvoxamine may compete with PS for binding to the pleckstrin homology domain of dynamin I. On the other hand, sertraline was a mixed type inhibitor with respect to both GTP and PS. Our results indicate that sertraline and fluvoxamine may regulate the transportation of neurotransmitters by modulating synaptic vesicle endocytosis via the inhibition of dynamin I GTPase.

AB - Neuronal dynamin I plays a critical role in the recycling of synaptic vesicles, and thus in nervous system function. We expressed and purified dynamin I to explore potentially clinically useful endocytosis inhibitors and to examine the mechanism of their action. We estimated the IC50 of nineteen psychotropic drugs for dynamin I. The IC50 values of two selective serotonin reuptake inhibitors (sertraline and fluvoxamine) were 7.3±1.0 and 14.7±1.6 μM, respectively. Kinetic analyses revealed that fluvoxamine is a noncompetitive inhibitor of dynamin I guanosine triphosphatase (GTPase) with respect to guanosine 5′-triphosphate (GTP) and a competitive inhibitor with respect to L-phosphatidylserine (PS). Fluvoxamine may compete with PS for binding to the pleckstrin homology domain of dynamin I. On the other hand, sertraline was a mixed type inhibitor with respect to both GTP and PS. Our results indicate that sertraline and fluvoxamine may regulate the transportation of neurotransmitters by modulating synaptic vesicle endocytosis via the inhibition of dynamin I GTPase.

KW - Dynamin

KW - Endocytosis

KW - Guanosine triphosphatase

KW - Inhibitor

KW - Selective serotonin reuptake inhibitor

UR - http://www.scopus.com/inward/record.url?scp=48849085276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48849085276&partnerID=8YFLogxK

U2 - 10.1248/bpb.31.1489

DO - 10.1248/bpb.31.1489

M3 - Article

C2 - 18670077

AN - SCOPUS:48849085276

VL - 31

SP - 1489

EP - 1495

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 8

ER -